← Leaderboards
Robert J Henderson
Jaeb Center For Health Research, Inc.
$2,611,523
Attributed
$7,277,530
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2021–25$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,277,530 · 3
By mechanism
R01$3,788,441 · 2
U01$3,489,089 · 1
Top collaborators
- Yogish C. Kudva4 shared
- Richard E Pratley4 shared
- Naomi Sage Chaytor3 shared
- Michael R Rickels3 shared
- Ruth S Weinstock2 shared
- Vernon M. Chinchilli1 shared
Most similar at Jaeb Center For Health Research, Inc.
Same institution · by research overlap
- Roy W Beck$90,066,593
- Kellee Miller$263,543
Others in their field
Other Emerging Leaders on “Randomized”
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Abraham Aizer Brody · New York University School Of Medicine$23,359,458
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
Research focus
RandomizedDiabetes MellitusHypoglycemiaAdultTechnologyGlycosylated Hemoglobin AInsulin-Dependent Diabetes MellitusDevicesSafetyDiabetes ManagementPumpParticipantImpaired CognitionRunningHybridsInsulinEventClinicClinical TrialsDiabetes DistressGlucoseEfficacy EvaluationElderlyTraining
Grant awards (5)
The Biostatistics Research Center for the Impaired Awareness of Hypoglycemia Consortium$3,489,089
U01 · FY2025 · DK
Care partner-assisted ImplementatiOn of Patch HybrId Closed Loop Insulin Delivery for Older Adults with T1D (COPILOT)$2,345,176
R01 · FY2025 · DK · contact PI
A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes$239,044
R01 · FY2023 · DK · contact PI
A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes$565,751
R01 · FY2022 · DK · contact PI
A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes$638,470
R01 · FY2021 · DK · contact PI